http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013542773-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-3181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2201-0627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-3144 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-4742 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-314 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1459 |
filingDate | 2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2013542773-A |
titleOfInvention | Continuous measurement of total hemoglobin |
abstract | The present application relates to continuous measurement of total hemoglobin (tHb) in whole blood. In one embodiment, different wavelengths are used for spectral intensity normalization and total hemoglobin calculation. Specifically, a first wavelength is used for normalization, which is substantially unaffected by changes in hemoglobin and oxygen saturation levels. The second wavelength is used to calculate total hemoglobin. The second wavelength is affected by changes in hemoglobin levels, but is substantially unaffected by changes in oxygen saturation levels. In another embodiment, both are affected by oxygen saturation, but continuous measurements can be made using two wavelengths that are both equally affected. In other words, the normalized intensity associated with the two wavelengths changes by an equal amount with an equal change in oxygen saturation level. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019515718-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478150-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10850046-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835718-B2 |
priorityDate | 2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291 |
Total number of triples: 23.